Candriam S.C.A. My Md Pharmaceuticals, Inc. Transaction History

Candriam S.C.A.

  • $17.1 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 09, 2021
SELL
$4.64 - $7.94 $83,858 - $143,499
-18,073 Closed
0 $0
Q2 2021

Jul 20, 2021
BUY
$3.39 - $6.98 $61,267 - $126,149
18,073 New
18,073 $114,000

Others Institutions Holding MYMD

# of Institutions
2
Shares Held
30.2K
Call Options Held
0
Put Options Held
0
View Full List

About MyMD Pharmaceuticals, Inc.

MYMD Quotes by TradingView
  • Ticker MYMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,470,000
  • Market Cap $67.5M
  • Description
  • MyMD Pharmaceuticals, Inc., a clinical development stage pharmaceutical company, focuses on developing various therapeutic platforms to treat the causes of disease. The company is developing MYMD-1, a drug platform based on a clinical stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and o...
More about MYMD
Track This Portfolio

Track Candriam S.C.A. Portfolio

Follow Candriam S.C.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

News

Stay updated on Candriam S.C.A. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email